Extravascular diffusion of tirapazamine: effect of metabolic consumption assessed using the multicellular layer model
- 1 October 1998
- journal article
- Published by Elsevier in International Journal of Radiation Oncology*Biology*Physics
- Vol. 42 (3) , 641-649
- https://doi.org/10.1016/s0360-3016(98)00268-5
Abstract
No abstract availableKeywords
This publication has 21 references indexed in Scilit:
- Modification of the antitumor activity of chemotherapeutic drugs by the hypoxic cytotoxic agent tirapazamineCancer Chemotherapy and Pharmacology, 1997
- Hypoxia-specific cytotoxins in cancer therapySeminars in Radiation Oncology, 1996
- Pretreatment oxygenation predicts radiation response in advanced squamous cell carcinoma of the head and neckRadiotherapy and Oncology, 1996
- Modification of hypoxia-induced radioresistance in tumors by the use of oxygen and sensitizersSeminars in Radiation Oncology, 1996
- Bioreductive drugs for cancer therapy: The search for tumor specificityInternational Journal of Radiation Oncology*Biology*Physics, 1994
- Intratumoral pO2 predicts survival in advanced cancer of the uterine cervixRadiotherapy and Oncology, 1993
- Tumor hypoxia can be exploited to preferentially sensitize tumors to fractionated irradiationInternational Journal of Radiation Oncology*Biology*Physics, 1991
- Oxygen distribution in squamous cell carcinoma metastases and its relationship to outcome of radiation therapyInternational Journal of Radiation Oncology*Biology*Physics, 1988
- SR-4233: A new bioreductive agent with high selective toxicity for hypoxic mammalian cellsInternational Journal of Radiation Oncology*Biology*Physics, 1986
- RADIOTHERAPY AND HYPERBARIC OXYGEN IN HEAD AND NECK CANCERThe Lancet, 1977